Protagonist and Takeda Announce Positive Topline Results from Phase 3 VERIFY Study of Rusfertide in Patients with Polycythemia Vera

Contributed by: Business Wire

Logo

Business Wire logo

Tags

Research
FDA
Clinical Trials
Cardiology
Biotechnology
Health
Pharmaceutical
Science
Oncology
Protagonist